Everything

 

DTaP Vaccine Adverse Side Effects | PRLog

DTaP Vaccine Adverse Side Effects. Vaccine side effects have been noted in the combined Diphtheria, Tetanus and Pertussis vaccination since it was licenses in the 1940’s. - PR11766573

Medical News: Tetanus Rare but Still Deadly - in Infectious Disease, General Infectious Disease

Although rare, tetanus is still a life-threatening disease in the U.S., largely because of inadequate vaccination and wound care prophylaxis, CDC researchers said.

Merck & Co., Inc. Obtains Exclusive Rights to Market and Distribute MassBiologics'

BOSTON&WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MassBiologics (MBL) of the University of Massachusetts Medical School and Merck&Co., Inc. (NYSE: MRK - News) announced today that they have entered into an agreement that provides Merck with exclusive rights to market and distribute MBL's tetanus

tetanus dangers

Information on tetanus bacteria and it's common breeding grounds.

australiandoctor.com.au

Home page Home This Week's Issue Jobs Education Video Contact Us Search: Login spacer Archive Earn CPD Points Services Education Classifieds Subscriptions > Australian Doctor

BAYTET

Pharmaceutical Preparations, Namely, Tetanus Immune Globuline For the Prophylaxis of Tetanus

doi:10.1016/S0140-6736(05)62861-9

THE LANCET Vol 349 • February 1, 1997 359 treatment with zidovudine and zalitabine, compared with zidovudine alone (p<0·05), which, because there are multiple comparisons, cannot be regarded as statistically significant. No benefit in terms of disease progression or death resulted from treatment

Experts call for free tetanus vaccine at 65

Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive Medicine Politics Practice Ideas Other stuff Jobs Search Experts call for free tetanus vaccine at 65 Universal funded tetanus vaccine

IMMUNITY AGAINST TETANUS AND EFFECT OF REVACCINATION 25-30 YEARS AFTER PRIMARY VACCINATION : The

IMMUNITY AGAINST TETANUS AND EFFECT OF REVACCINATION 25-30 YEARS AFTER PRIMARY VACCINATION. By - O. Simonsen, K. Kjeldsen, I. Heron

Merck News Item

Merck & Co., Inc. home investors newsroom licensing careers contact us About Us Our Values Leadership How We Operate Views and Positions Merck/Schering-Plough Merger Our History Corporate Responsibility Ethics and

Results 1-10 of 147
 


Refine by Content Type:



Refine by Source:

12 Sources ...